Emdeki Utama Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Emdeki Utama Tbk. trades at Rp179 (market cap 455.43B, 888.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Emdeki Utama Tbk. is far larger — about 2.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Emdeki Utama Tbk. is more actively traded (888.7K versus 96.7K). Which is the better fit depends on your goals.
| MDKI | OBAT | |
|---|---|---|
Market Cap | 455.43B | 167.37B |
Volume | 888.7K | 96.7K |
Lot | 8.89K | 967 |
Turnover | 158.08M | 23.82M |
Average Price | 177.88 | 246.34 |
Value | 158.08M | 23.82M |
Indicative Equilibrium Price | 180 | 248 |
Indicative Equilibrium Volume | 400 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Emdeki Utama (the Entity) was established based on Notarial Deed No. 33 of Hobropoerwanto, S.H., dated March 17, 1981.
Read more on MDKI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →